Kemper (KMPR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Net income of $73.7M ($1.14/share) in Q3 2024, reversing a $146.3M loss in Q3 2023, with adjusted consolidated net operating income of $105.0M ($1.62/share).
ROE reached 10.8% and adjusted ROE 16.7% for the quarter, with book value per share rising to $43.30 and adjusted book value per share to $27.88.
Specialty P&C segment delivered strong profitable growth, with sequential PIF growth of 4.5% and underlying combined ratio of 91.3%.
Life segment delivered stable operating results and strong returns, with adjusted net operating income of $15.0M.
Strengthened capital and liquidity positions, with parent company liquidity at $1.3B at quarter end.
Financial highlights
Net income of $73.7M; adjusted consolidated net operating income of $105.0M; net investment income reached $111.1M with a pre-tax equivalent annualized book yield of 4.8%.
Q3 2024 net income per share was $1.14 (basic), adjusted net operating income per share was $1.62 (diluted).
Book value per share increased to $43.30; adjusted book value per share rose to $27.88.
Catastrophe losses for the quarter totaled $16M, with $11M in non-core/preferred P&C and $3.6M in specialty P&C.
Total revenues for Q3 2024 were $1,178.9M, down 1.7% year-over-year due to the exit of Preferred Insurance business.
Outlook and guidance
Expect continued PIF and earned premium growth in specialty auto, with combined ratio remaining below 96% over the next 3–5 quarters.
Plan to retire $450M of senior notes due February 2025, supporting balance sheet strength.
Net investment income expected to run at $105–$107M per quarter.
Focus on long-term profitable growth and maintaining strong capital and liquidity positions.
Management expects continued improvement in Specialty P&C profitability, driven by rate increases and lower claim frequency.
Latest events from Kemper
- Key votes include director elections, executive pay, and auditor ratification for 2026.KMPR
Proxy filing25 Mar 2026 - Annual meeting features director elections, say-on-pay, auditor ratification, and strong governance.KMPR
Proxy filing25 Mar 2026 - Operational focus, tech investment, and regulatory shifts drive growth and profitability outlook.KMPR
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Q4 net loss of $8m driven by claim severity and refunds; restructuring and new products target recovery.KMPR
Q4 20254 Feb 2026 - Q2 2024 net income reached $75.4M with 11.5% ROE and 4.6% PIF growth, outlook remains strong.KMPR
Q2 20242 Feb 2026 - Strong growth and profitability return as rate hikes and market conditions drive expansion.KMPR
Raymond James & Associates’ 46th Annual Institutional Investors Conference 202523 Dec 2025 - Q4 net income more than doubled year-over-year, driven by strong underwriting and capital actions.KMPR
Q4 202420 Dec 2025 - Annual meeting covers director elections, pay, equity plan, and auditor, with strong 2024 results.KMPR
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay, omnibus plan, and auditor ratification.KMPR
Proxy Filing1 Dec 2025